These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2431948)
1. [Relation between serum markers of hepatitis B virus and alpha fetoprotein in hepatocellular carcinoma in France]. Attali P; Prod'homme S; Pelletier G; Papoz L; Buffet C; Etienne JP Gastroenterol Clin Biol; 1986 Oct; 10(10):637-40. PubMed ID: 2431948 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan. Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990 [TBL] [Abstract][Full Text] [Related]
3. [Hepatocellular carcinoma in France. Clinical, biological and virological aspects in 197 patients]. Attali P; Prod'homme S; Pelletier G; Papoz L; Buffet C; Etienne JP Gastroenterol Clin Biol; 1985 May; 9(5):396-402. PubMed ID: 2989069 [TBL] [Abstract][Full Text] [Related]
4. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
5. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507 [TBL] [Abstract][Full Text] [Related]
6. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area. Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989 [TBL] [Abstract][Full Text] [Related]
7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
8. [Markers of the hepatitis B virus and chronic alcoholism. Prevalence and risk factors]. Renard P; Hillon P; Bedenne L; Fourot M; Milan C; Faivre J; Klepping C Ann Gastroenterol Hepatol (Paris); 1991; 27(1):7-12. PubMed ID: 1851406 [TBL] [Abstract][Full Text] [Related]
9. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859 [TBL] [Abstract][Full Text] [Related]
10. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin]. Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087 [TBL] [Abstract][Full Text] [Related]
11. [Clinical and etiologic features of hepatocarcinoma in Sicily]. Carroccio A; Soresi M; Bonfissuto G; Magliarisi C; Anastasi G; Vuturo O; Notarbartolo A; Montalto G Ann Ital Med Int; 1999; 14(4):233-8. PubMed ID: 10638015 [TBL] [Abstract][Full Text] [Related]
12. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan. Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941 [TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis. Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S; Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087 [TBL] [Abstract][Full Text] [Related]
14. The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma. Furui J; Furukawa M; Kanematsu T Hepatogastroenterology; 1995; 42(5):445-9. PubMed ID: 8751193 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus infection predicts extrahepatic metastasis after hepatic resection in patients with large hepatocellular carcinoma. Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S Ann Surg Oncol; 2007 Nov; 14(11):3181-7. PubMed ID: 17846843 [TBL] [Abstract][Full Text] [Related]
16. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study. Tanaka K; Nagao Y; Ide T; Kumashiro R; Sata M Int J Mol Med; 2006 May; 17(5):827-32. PubMed ID: 16596267 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients. Okuda H; Obata H; Motoike Y; Hisamitsu T Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis G virus infection in patients with hepatocellular carcinoma in Recife, Brazil. Leão-Filho GC; Lopes EP; Ferraz AA; Moura I; Pernambuco JR; Reis C; Silva AE; Ferraz ML Jpn J Clin Oncol; 2007 Aug; 37(8):632-6. PubMed ID: 17704535 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma. Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625 [TBL] [Abstract][Full Text] [Related]
20. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Peng YC; Chan CS; Chen GH Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]